# TRISCEND JAPAN Study

> **NCT05760989** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 45 (estimated)

## Conditions studied

- Tricuspid Valve Regurgitation
- Heart Valve Diseases
- Cardiovascular Diseases

## Interventions

- **DEVICE:** Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System

## Key facts

- **NCT ID:** NCT05760989
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-06
- **Primary completion:** 2025-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05760989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05760989, "TRISCEND JAPAN Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05760989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*